$DMAC

$8.69 -$0.05 (0.57%) Close

$DMAC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 53.9M shares outstanding

Who owns DMAC?

By type of holder

Institutions 23.1% Insiders 50.8% Everyone else 26.1%

Concentration Top 10 holders own 18.5%

Cooperman Leon G 6.4% · BlackRock, Inc. 4.2%

Institutional ownership

23.1%

+1.4 pts vs last qtr

Institutional holders

-12 vs last qtr

Net shares bought

+739.2K

by institutions in Q2 2026

New / sold out

10 / 22

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Cooperman Leon G +1.4M
BlackRock, Inc. +396.1K

Biggest sellers in Q2 2026

Paragon Associates & Paragon Associates II Joint Venture SOLD OUT −875.0K
First Manhattan Co. LLC. SOLD OUT −455.0K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for DiaMedica Therapeutics Inc in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for DiaMedica Therapeutics Inc.

How patient are the owners?

Institutional shares by how long they've been held

5+ years68% 3–5 years7% 1–3 years10% Under 1 year15%

Quarterly turnover

21.0%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting DMAC on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
CL Cooperman Leon G	3.5M	6.40%	+1.4M (+70.8%)	≤2021	0.7%
Shares held by quarter Peak holding3.5M (Q2'26) Change over 8 quarters+1.9M Share of the company6.400% Cooperman Leon G's full portfolio →
B BlackRock, Inc.	2.3M	4.18%	+396.1K (+21.3%)	≤2021	0.0%
Shares held by quarter Peak holding2.3M (Q2'26) Change over 8 quarters+2.1M Share of the company4.180% BlackRock, Inc.'s full portfolio →

Cooperman Leon G

3.5M

% of company

6.40%

Change vs last qtr

+1.4M (+70.8%)

Held since

≤2021

BlackRock, Inc.

2.3M

% of company

4.18%

Change vs last qtr

+396.1K (+21.3%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding DiaMedica Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting DMAC on Form N-PORT; together they hold 6.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IR iShares Russell 2000 ETF iShares Trust	$6.57M	933.3K	1.73%	0.01%	June 30, 2026
FS Fidelity Small Cap Index Fund Fidelity Salem Street Trust	$2.53M	399.6K	0.74%	0.01%	July 31, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$6.57M

% of company

1.73%

% of the fund

0.01%

As of

June 30, 2026

Fidelity Small Cap Index Fund

Fidelity Salem Street Trust

Position value

$2.53M

% of company

0.74%

% of the fund

0.01%

As of

July 31, 2026

23 more funds behind a free account

See every fund holding DiaMedica Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
GR Giuffre Randall Michael Insider	445.2K	0.83%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.830% Giuffre Randall Michael's insider activity →
PJ Parsons James T. Insider	97.9K	0.18%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.180% Parsons James T.'s insider activity →

Giuffre Randall Michael

Insider

445.2K

% of company

0.83%

Change vs last qtr

—

Held since

—

Parsons James T.

Insider

97.9K

% of company

0.18%

Change vs last qtr

—

Held since

—

1 more holders behind a free account

See every insider and 5%+ holder of DiaMedica Therapeutics Inc.

Comments